Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Lufax Holding Ltd — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Lufax Holding Ltd trades at $0.85 (market cap $894.58M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 34.7× Lufax Holding Ltd's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals.
| GEHC | LU | |
|---|---|---|
Market Cap | $31.07B | $894.58M |
Volume | 3,443,020 | 1,044,976 |
Sector | Health | Financials |
52-Week High | $88.16 | $3.64 |
52-Week Low | $59.48 | $0.86 |
Enterprise Value | $39.53B | $58.66B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Lufax Holding Ltd (LU) trades at $0.9201, down 0.47% on the day, reflecting ongoing challenges in China's consumer lending market. The stock shows a bearish technical signal with negative earnings trends, having missed EPS estimates for three consecutive quarters. Recent corporate actions include a 10:1 reverse stock split effective October 2026. Despite deep value metrics (P/S 0.24, P/B 0.07), the company reports negative net income margins and declining revenue, with 2025 showing a $2.10B loss on $23.11B revenue.
LU presents a high-risk opportunity with significant analyst divergence. While 69% of analysts rate it Buy citing deep valuation and Ping An backing, fundamental deterioration and regulatory headwinds create substantial downside risk. The stock's appeal rests on potential capital return catalysts rather than business turnaround, requiring careful risk assessment given China's tightening financial regulations and persistent operational losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
